Stability of Antimicrobial Decapeptide (KSL) and Its Analogues for Delivery in the Oral Cavity
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To investigate the stability of KSL, an antimicrobial decapeptide, and its analogues, in human saliva and simulated gastric fluid for delivery in the oral cavity.
Materials and Methods
The degradation products of KSL in human saliva and simulated gastric fluid were separated by reversed-phase HPLC and their structures were identified by electrospray ionization-mass spectrometry. Analogues of KSL were synthesized by solid-phase synthesis procedure. Their enzymatic stabilities and antimicrobial activities were studied.
KSL was degraded by the peptide bond cleavages at Lys6–Val7 in the human saliva and Phe5–Lys6 in simulated gastric fluids. Three analogues of KSL were synthesized; the Lys6 residue was either methylated (KSL-M), or replaced with Trp (KSL-W), or the d-form of Lys (KSL-D). The KSL analogues were much more stable than the native KSL, with the rank order of stability being KSL-D > KSL-W > KSL-M > KSL in human saliva. However, in simulated gastric fluid, while KSL-D was still stable, KSL-W was significantly degraded. In addition, KSL-D significantly lost the antimicrobial activity, whereas KSL-W completely preserved the activity against several oral bacteria. In a chewing gum formulation, KSL-W showed a more sustained release profile as compared with the native KSL.
This study suggests that KSL-W could be used as an antiplaque agent in a chewing gum formulation.
- M. Zasloff. Antimicrobial peptides of multicellular organisms. Nature 415:389–395 (2002). CrossRef
- S. Y. Hong, J. E. Oh, M. Kwon, M. J. Choi, J. H. Lee, B. L. Lee, H. M. Moon, and K. H. Lee. Identification and characterization of novel antimicrobial decapeptides generated by combinational chemistry. Antimicrob. Agents Chemother. 42:2534–2541 (1998).
- S. P. Concannon, T. D. Crowe, J. J. Abercrombie, C. M. Molina, P. Hou, D. K. Sukumaran, P. A. Raj, and K. P. Leung. Susceptibility of oral bacteria to an antimicrobial decapeptide. J. Med. Microbiol. 52:1083–1093 (2003). CrossRef
- K. P. Leung, T. D. Crowe, J. J. Abercrombie, C. M. Molina, C. J. Bradshaw, C. L. Jensen, Q. Luo, and G. A. Thompson. Control of oral biofilm formation by an antimicrobial decapeptide. J. Dent. Res. 84:1172–1177 (2005).
- A. A. Scheie. Modes of action of currently known chemical anti-plaque agents other than chlorhexidine. J. Dent. Res. 68:1609–1616 (1989).
- P. C. Baehni and Y. Takeuchi. Anti-plaque agents in the prevention of biofilm-associated oral diseases. Oral Dis. 9:23–29 (2003). CrossRef
- M. R. Rassing. Chewing gum as a drug delivery system. Adv. Drug Deliv. Rev. 13:89–121 (1994). CrossRef
- J. Ainamo and H. Etemadzadeh. Prevention of plaque growth with chewing gum containing chlorhexidine acetate. J. Clin. Periodontol. 14:524–527 (1987). CrossRef
- A. J. Smith, J. Moran, L. V. Dangler, R. S. Leight, and M. Addy. The efficacy of an anti-gingivitis chewing gum. J. Clin. Periodontol. 23:19–23 (1996). CrossRef
- G. Tellefsen, G. Larsen, R. Kaligithi, G. J. Zimmerman, and M. E. Wikesjo. Use of chlorhexidine chewing gum significantly reduces dental plaque formation compared to use of similar xylitol and sorbitol products. J. Periodontol. 67:181–183 (1996).
- T. Imfeld. Chewing gum—facts and fiction: a review of gum-chewing and oral health. Crit. Rev. Oral Biol. Med. 10:405–419 (1999). CrossRef
- D. H. Na, J. Faraj, Y. Capan, K. P. Leung, and P. P. DeLuca. Chewing gum of antimicrobial decapeptide (KSL) as a sustained antiplaque agent: preformulation study. J. Control. Release 107:122–130 (2005). CrossRef
- J. L. Reubsaet, J. H. Beijnen, A. Bult, R. J. van Maanen, J. A. Marchal, and W. J. Underberg. Analytical techniques used to study the degradation of proteins and peptides: chemical instability. J. Pharm. Biomed. Anal. 17:955–978 (1998). CrossRef
- D. H. Na, Y. S. Youn, S. D. Lee, M.W. Son, W. B. Kim, P. P. DeLuca, and K. C. Lee. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry. J. Control. Release 92:291–299 (2003). CrossRef
- D. H. Na, Y. S. Youn, E. J. Park, J. M. Lee, O. R. Cho, K. R. Lee, S. D. Lee, S. D. Yoo, P. P. DeLuca, and K. C. Lee. Stability of PEGylated salmon calcitonin in nasal mucosa. J. Pharm. Sci. 93:256–261 (2004). CrossRef
- H. Okamoto, H. Taguchi, K. Iida, and K. Danio. Development of polymer film dosage forms of lidocaine for buccal administration. I. Penetration rate and release rate. J. Control. Release 77:253–260 (2001). CrossRef
- D. H. Na, P. P. DeLuca, and K. C. Lee. Direct determination of the peptide content in microspheres by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal. Chem. 76:2669–2673 (2004). CrossRef
- C. Kvist, S. B. Andersson, S. Fors, B. Wennergren, and J. Berglund. Apparatus for studying in vitro drug release from medicated chewing gums. Int. J. Pharm. 189:57–65 (1999). CrossRef
- Stability of Antimicrobial Decapeptide (KSL) and Its Analogues for Delivery in the Oral Cavity
Volume 24, Issue 8 , pp 1544-1550
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- antimicrobial peptide
- antiplaque agent
- chewing gum
- peptide analogue
- Industry Sectors
- Author Affiliations
- 1. College of Pharmacy, Kyungsung University, Busan, 608-736, South Korea
- 2. Faculty of Pharmaceutical Sciences, University of Kentucky College of Pharmacy, 725 Rose Street, Lexington, KY, 40536, USA
- 3. Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, 06100, Turkey
- 4. Microbiology Branch, US Army Dental and Trauma Research Detachment, Walter Reed Army Institute of Research, Great Lakes, IL, 60088, USA